title: Oxygen uptake, ventilation, and symptoms during low-frequency versus high-frequency NMES in COPD: a pilot study.
abstract: Transcutaneous neuromuscular electrical stimulation (NMES) involves the application of an electrical current through electrodes placed on the skin over the targeted muscles. During high-frequency NMES (HF-NMES), oxygen uptake, minute ventilation, and the degree of symptom perception (dyspnea and fatigue) have been shown to be acceptable in chronic obstructive pulmonary disease (COPD). Currently, oxygen uptake and ventilation load have never been assessed during low-frequency NMES (LF-NMES) of the lower-limb muscles. The purpose of this study was to compare prospectively oxygen uptake, ventilation, and symptom perception during a single session of LF-NMES versus a single session of HF-NMES of quadriceps muscles in patients with COPD. In 17 COPD patients (mean FEV(1) = 45% predicted, mean body mass index = 26.2 kg/m(2)), peak exercise capacity, functional exercise capacity, and the Medical Research Council dyspnea grade were evaluated. In addition, oxygen uptake, minute ventilation, heart rate, and Borg symptom scores were assessed during one session of LF-NMES (15 Hz) and one session of HF-NMES (75 Hz) and compared with peak values. Mean oxygen uptake (LF-NMES: 327 ml/min vs. HF-NMES: 315 ml/min), minute ventilation (LF-NMES: 14 L vs. HF-NMES: 15 L), and heart rate (LF-NMES: 86 BPM vs. HF-NMES: 83 BPM) were similar during both NMES frequencies. Patients used a relatively low proportion of their peak aerobic capacity during both NMES sessions (LF-NMES: 34% vs. HF-NMES: 33%; P = 0.397). In addition, symptom Borg scores for dyspnea and leg fatigue were also comparable. Oxygen uptake, ventilation, and symptoms of dyspnea and fatigue were comparable and tolerable during LF-NMES and HF-NMES in patients with COPD. Therefore, LF-NMES and HF-NMES may both be suitable rehabilitative modalities to be used in severely dyspneic patients with lower-limb muscle dysfunction.
authors.affiliation: Program Development Centre, Ciro+, Hornerheide 1, Horn, The Netherlands. mauricesillen@ciro-horn.nl
authors.forename: Maurice J H
authors.initials: MJ
authors.lastname: Sillen
authors.forename: Emiel F M
authors.initials: EF
authors.lastname: Wouters
authors.forename: Frits M E
authors.initials: FM
authors.lastname: Franssen
authors.forename: Kenneth
authors.initials: K
authors.lastname: Meijer
authors.forename: Koen H P
authors.initials: KH
authors.lastname: Stakenborg
authors.forename: Martijn A
authors.initials: MA
authors.lastname: Spruit
mesh_terms: D000368:Aged; D018592:Cross-Over Studies; D004417:Dyspnea / Q000209:etiology / Q000628:therapy; D017079:Exercise Tolerance; D005260:Female; D005541:Forced Expiratory Volume; D006339:Heart Rate; D006801:Humans; D008168:Lung / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D018763:Muscle Fatigue; D009426:Netherlands; D010100:Oxygen / Q000378:metabolism*; D010865:Pilot Projects; D011446:Prospective Studies; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D012123:Pulmonary Ventilation; D052097:Quadriceps Muscle / Q000294:innervation*; D015656:Respiratory Mechanics; D004561:Transcutaneous Electric Nerve Stimulation / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D010100:Oxygen